March 28th 2025
A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Genetic Influence on Fears Changes Over Time
April 8th 2008Genetic and environmental factors both have an impact on fears in middle childhood and early adulthood but they act in a dynamic way and change over time, according to a report published in the April issue of the Archives of General Psychiatry.
Bedroom Television Bad Influence on Teens
April 7th 2008Older adolescents who have a television in their bedroom are less physically active, have fewer family meals and a poorer diet compared to their counterparts without a bedroom television, according to a report published in the April issue of Pediatrics.
FDA: Safety Warning Issued for Influenza Drug Relenza
April 3rd 2008The maker of the antiviral drug Relenza (zanamivir) informed health care professionals this week of a potential risk of behavioral changes and delirium associated with the drug's use. Relenza is approved for the treatment of influenza A and B.
FDA: Delirium Tied to Use of Tamiflu in Influenza
March 5th 2008The U.S. Food and Drug Administration, together with Roche Laboratories, Inc., the maker of Tamiflu (oseltamivir), have informed health care professionals of neuropsychiatric events associated with use of the antiviral drug in patients with influenza. The Tamiflu package insert has been updated to reflect these safety concerns.
FDA: Delirium Tied to Use of Tamiflu in Influenza
March 5th 2008The U.S. Food and Drug Administration, together with Roche Laboratories, Inc., the maker of Tamiflu (oseltamivir), have informed health care professionals of neuropsychiatric events associated with use of the antiviral drug in patients with influenza. The Tamiflu package insert has been updated to reflect these safety concerns.
FDA Agrees to Expand Next Year's Influenza Vaccine
February 22nd 2008The U.S. Food and Drug Administration announced plans this week to expand next year's flu vaccine by including three new flu strains, in the hopes of producing a vaccine that is more effective than this year's vaccine. Researchers at the U.S. Centers for Disease Control and Prevention report on this season's flu activity in the Feb. 15 issue of the Morbidity and Mortality Weekly Report.
Folk Remedy as a Cause of Septicemia in a Child With Leukemia
December 1st 2007A 15-year-old Hispanic boy with refractory T-cell acute lymphoid leukemia was hospitalized because of fever and pain and swelling of the right knee of 3 days' duration. The patient was taking nelarabine for a recurrence of his leukemia, which was diagnosed a year earlier. He appeared nontoxic. His temperature was 39.28C (102.68F). Other vital signs were within normal limits. The right knee was warm and tender, with mild restriction of movement.
Vaccine-Associated Herpes Zoster
October 1st 2007A 23-month-old girl presented with an erythematous papular rash on her torso that extended in a linear pattern around to the back. The mother first noticed the rash while bathing the child 3 days earlier. The child had no associated itching, irritability, or fever, but she had mild rhinorrhea preceding the rash that resolved without treatment. The patient and her older sibling were cared for at home by their mother.
Middle School: A Time for Maturation-and Vaccination
September 1st 2007ABSTRACT: The pre-middle school well child visit is now an important landmark on the vaccine schedule. The pre-kindergarten visit no longer has the distinction of being the last of the visits for "school shots." Pediatricians should emphasize this point at the 4- to 6-year-old well child visit so that parents are aware of the need for another series of vaccines in about 5 years.
Immunizing the College Student: REFERENCES:
September 1st 2007ABSTRACT: College is a time of new exposures, risk-taking, and adventure. Thus, protection with proper immunization is paramount. Pediatricians should offer the recommended vaccines whether required for college entry or not. When the young adult comes to the office to have the college health form completed and signed, seize the opportunity to tout the benefits of pre-college vaccination.
Elementary School: REFERENCES:
September 1st 2007ABSTRACT: Vaccination must be promoted before and on entry into elementary school. Not only does vaccination provide substantial health benefits to society, it is the law. The recommended childhood vaccination schedule changes on a yearly basis. Similarly, state vaccination requirements for school entry also may change yearly to accommodate these recommendations. Pediatricians need to remain abreast of the most recent vaccine information and to offer all vaccines at the appropriate well child visits. The goal is to limit the number or eliminate altogether the need for catch-up vaccines when the time comes for entry into elementary school.
Secondary Syphilis in a Teenage Boy
August 1st 2007This rash on a teenage boy's palms began on his hands and spread to his torso and upper and lower extremities over several days. He had no pain or pruritus. Two weeks before the lesions appeared, he had experienced fatigue, fever, and myalgia of 1 week's duration.
Group A -Hemolytic Streptococcal Vulvovaginitis
July 1st 2007An otherwise healthy 3-year-old girl was brought for evaluation of fever, sore throat, and shaking chills of 12 hours' duration. She had beefy-red, posterior oropharyngeal erythema and a scarlatiniform rash on her shoulder that had been present for a few hours. The rash faded out over her chest but reappeared in the perineum and lower abdomen. She also had vulvovaginal inflammation with surrounding erythema. The mother was surprised to see the inflammation, but in retrospect added that the child had complained of vaginal discomfort as well. A rapid antigen test for group A b-hemolytic streptococci (GABHS) from a swab of the oropharynx was positive.
Update on Pediatric Rheumatology
July 1st 2007ABSTRACT: Dramatic progress has been made in our understanding of pediatric rheumatic disease. Various classification systems help identify juvenile idiopathic arthritis (JIA), which involves unique considerations that distinguish it from rheumatoid arthritis in adults. Vaccination issues are important for children with JIA. Renal involvement with systemic lupus erythematosus (SLE) is more common and more severe in children than in adults, but treatment of children who have SLE is similar to that of adults. Neonatal lupus erythematosus may occur in infants whose mothers have SLE. Juvenile dermatomyositis is associated with significant morbidity and mortality. Kawasaki disease is a common vasculitis of childhood, especially in infants and toddlers. Each of at least 8 major familial periodic fever clinical syndromes has specific distinguishing characteristics.